Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group
Status:
Completed
Trial end date:
2023-11-11
Target enrollment:
Participant gender:
Summary
The current clinical trial will include 160 children who will be presented with vomiting to
the Outpatient Department of the Children's Hospital, Faculty of Medicine, Ain Shams
University. Participants will be assigned randomly to receive either a dispersible film
Ondansetron or oral Granisetron. After initial assessment, both groups will be followed up
after 6 and 48 hours to check the frequency of vomiting, diarrhea, fever, headache as well as
the return of appetite and the need for further treatment. The impact of nausea and vomiting
on patients' daily lives will be assessed using a modified version of the Functional Living
Index-Emesis (FLIE).